trending Market Intelligence /marketintelligence/en/news-insights/trending/qhvoLpMCOtZuqhGm3rx7Dw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Medica Clinical Nord Q3 profit climbs 47.1% YOY

Complying with International Financial Reporting Standard IFRS 9

Industries Most and Least Impacted by COVID-19 from a Probability of Default Perspective – September 2020 Update

Gold RRS 2020 — Top Gold Producers' Reserves In Decline

Infrastructure Issues: Understanding and Mitigating Risks

Medica Clinical Nord Q3 profit climbs 47.1% YOY

MedicaNatumin AB (publ) said its normalized net income for the third quarter came to 1.6 million kronor, a rise of 47.1% from 1.1 million kronor in the year-earlier period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

The normalized profit margin increased to 5.2% from 5.2% in the year-earlier period.

Total revenue increased 45.6% on an annual basis to 30.0 million kronor from 20.6 million kronor, and total operating expenses climbed 35.6% from the prior-year period to 27.4 million kronor from 20.2 million kronor.

Reported net income increased 75.0% on an annual basis to 2.8 million kronor, or 1 öre per share, from 1.6 million kronor, or 1 öre per share.

As of Oct. 27, US$1 was equivalent to 9.05 Swedish kronor.